nach oben

European Journal of Nutrition

Erschienen in:

10.12.2019 | Original Contribution

Associations between tea and coffee beverage consumption and the risk of lung cancer in the Singaporean Chinese population

verfasst von: Wei Jie Seow, Woon-Puay Koh, Aizhen Jin, Renwei Wang, Jian-Min Yuan

Erschienen in: European Journal of Nutrition | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Tea and coffee are widely consumed beverages. Tea flavonoids have been shown to inhibit lung tumorigenesis using in vitro and in vivo models. Conversely, coffee contains complex mixtures of biochemically active compounds, some of which may have genotoxic and mutagenic properties. However, previous epidemiologic studies have shown inconsistent results on tea and coffee in relation to lung cancer risk.

Methods

The Singapore Chinese Health Study is a population-based prospective cohort of 63,257 Singaporean Chinese men and women, with an average of 17.7 years of follow-up. Information on tea and coffee consumption and other lifestyle factors was collected through in-person interviews at baseline. Multivariable Cox regression models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the associations with adjustment for potential confounders.

Results

There were 1486 incident lung cancer cases. Compared to non-daily coffee drinkers, HRs (95% CIs) of lung cancer risk for those consuming one, two, and three or more cups of coffee per day were 1.18 (1.02–1.36), 1.21 (1.05–1.40), and 1.32 (1.08–1.62) respectively (P for trend = 0.0034). The highest category of black tea consumption (at least 2 cups per day) was inversely associated with risk of lung cancer [HR (95% CI) = 0.73 (0.53–0.99)], particularly among men [HR (95% CI) = 0.67 (0.47–0.95)], compared to less-than-weekly black tea drinkers, although the interaction by sex was not statistically significant.

Conclusions

Coffee beverage consumption was associated with higher risk of developing lung cancer. On the other hand, black tea intake was associated with lower risk of lung cancer among men in our cohort, and further studies are needed to confirm this association.

Nur mit Berechtigung zugänglich

Nehlig A, Debry G (1994) Potential genotoxic, mutagenic and antimutagenic effects of coffee: a review. Mutat Res 317(2):145–162CrossRef

Koh WP, Yuan JM, Sun CL, Lee HP, Yu MC (2005) Middle-aged and older Chinese men and women in Singapore who smoke have less healthy diets and lifestyles than nonsmokers. J Nutr 135(10):2473–2477. https://doi.org/10.1093/jn/135.10.2473CrossRefPubMed

Treur JL, Taylor AE, Ware JJ, McMahon G, Hottenga JJ, Baselmans BM, Willemsen G, Boomsma DI, Munafo MR, Vink JM (2016) Associations between smoking and caffeine consumption in two European cohorts. Addiction 111(6):1059–1068. https://doi.org/10.1111/add.13298CrossRefPubMedPubMedCentral

Vuong QV (2014) Epidemiological evidence linking tea consumption to human health: a review. Crit Rev Food Sci Nutr 54(4):523–536. https://doi.org/10.1080/10408398.2011.594184CrossRefPubMed

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–386. https://doi.org/10.1002/ijc.29210CrossRef

Steward B, Wild C (2014) World Cancer Report 2014. Lyon

Lam TK, Gallicchio L, Lindsley K, Shiels M, Hammond E, Tao XG, Chen L, Robinson KA, Caulfield LE, Herman JG, Guallar E, Alberg AJ (2009) Cruciferous vegetable consumption and lung cancer risk: a systematic review. Cancer Epidemiol Biomark Prev 18(1):184–195. https://doi.org/10.1158/1055-9965.EPI-08-0710CrossRef

Yuan JM, Stram DO, Arakawa K, Lee HP, Yu MC (2003) Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese Health Study. Cancer Epidemiol Biomark Prev 12(9):890–898

Yuan JM, Ross RK, Chu XD, Gao YT, Yu MC (2001) Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China. Cancer Epidemiol Biomark Prev 10(7):767–773

10.

London SJ, Yuan JM, Chung FL, Gao YT, Coetzee GA, Ross RK, Yu MC (2000) Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet 356(9231):724–729. https://doi.org/10.1016/S0140-6736(00)02631-3CrossRefPubMed

11.

Guertin KA, Freedman ND, Loftfield E, Graubard BI, Caporaso NE, Sinha R (2016) Coffee consumption and incidence of lung cancer in the NIH-AARP Diet and Health Study. Int J Epidemiol 45(3):929–939. https://doi.org/10.1093/ije/dyv104CrossRefPubMed

12.

Xie Y, Qin J, Nan G, Huang S, Wang Z, Su Y (2016) Coffee consumption and the risk of lung cancer: an updated meta-analysis of epidemiological studies. Eur J Clin Nutr 70(2):199–206. https://doi.org/10.1038/ejcn.2015.96CrossRefPubMed

13.

Nomura A, Heilbrun LK, Stemmermann GN (1986) Prospective study of coffee consumption and the risk of cancer. J Natl Cancer Inst 76(4):587–590CrossRef

14.

Stensvold I, Jacobsen BK (1994) Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5(5):401–408CrossRef

15.

Bae JM, Li ZM, Shin MH, Kim DH, Lee MS, Ahn YO (2013) Pulmonary tuberculosis and lung cancer risk in current smokers: the Seoul Male Cancer Cohort Study. J Korean Med Sci 28(6):896–900. https://doi.org/10.3346/jkms.2013.28.6.896CrossRefPubMedPubMedCentral

16.

Ganesh B, Sushama S, Monika S, Suvarna P (2011) A case–control study of risk factors for lung cancer in Mumbai, India. Asian Pac J Cancer Prev 12(2):357–362PubMed

17.

Sanikini H, Radoi L, Menvielle G, Guida F, Mattei F, Cenee S, Cyr D, Sanchez M, Velten M, Carton M, Schmaus A, Luce D, Stucker I (2015) Coffee consumption and risk of lung cancer: the ICARE study. Eur J Epidemiol 30(1):81–85. https://doi.org/10.1007/s10654-014-9976-2CrossRefPubMed

18.

Mettlin C (1989) Milk drinking, other beverage habits, and lung cancer risk. Int J Cancer 43(4):608–612CrossRef

19.

Takezaki T, Hirose K, Inoue M, Hamajima N, Yatabe Y, Mitsudomi T, Sugiura T, Kuroishi T, Tajima K (2001) Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas. Br J Cancer 84(9):1199–1206. https://doi.org/10.1054/bjoc.2001.1722CrossRefPubMedPubMedCentral

20.

Baker JA, McCann SE, Reid ME, Nowell S, Beehler GP, Moysich KB (2005) Associations between black tea and coffee consumption and risk of lung cancer among current and former smokers. Nutr Cancer 52(1):15–21. https://doi.org/10.1207/s15327914nc5201_2CrossRefPubMed

21.

Luqman M, Javed MM, Daud S, Raheem N, Ahmad J, Khan AU (2014) Risk factors for lung cancer in the Pakistani population. Asian Pac J Cancer Prev 15(7):3035–3039CrossRef

22.

Chiu YL, Wang XR, Qiu H, Yu IT (2010) Risk factors for lung cancer: a case–control study in Hong Kong women. Cancer Causes Control 21(5):777–785. https://doi.org/10.1007/s10552-010-9506-9CrossRefPubMed

23.

Tang N, Wu Y, Ma J, Wang B, Yu R (2010) Coffee consumption and risk of lung cancer: a meta-analysis. Lung Cancer 67(1):17–22. https://doi.org/10.1016/j.lungcan.2009.03.012CrossRefPubMed

24.

Galarraga V, Boffetta P (2016) Coffee drinking and risk of lung cancer—a meta-analysis. Cancer Epidemiol Biomarkers Prev 25(6):951–957. https://doi.org/10.1158/1055-9965.EPI-15-0727CrossRefPubMed

25.

Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K, International Agency for Research on Cancer Monograph Working Group (2016) Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol 17(7):877–878. https://doi.org/10.1016/s1470-2045(16)30239-xCrossRefPubMed

26.

Lin IH, Ho ML, Chen HY, Lee HS, Huang CC, Chu YH, Lin SY, Deng YR, He YH, Lien YH, Hsu CW, Wong RH (2012) Smoking, green tea consumption, genetic polymorphisms in the insulin-like growth factors and lung cancer risk. PLoS One 7(2):e30951. https://doi.org/10.1371/journal.pone.0030951CrossRefPubMedPubMedCentral

27.

Pasquet R, Karp I, Siemiatycki J, Koushik A (2016) The consumption of coffee and black tea and the risk of lung cancer. Ann Epidemiol 26(11):757–763e752. https://doi.org/10.1016/j.annepidem.2016.09.001CrossRefPubMed

28.

Wang L, Zhang X, Liu J, Shen L, Li Z (2014) Tea consumption and lung cancer risk: a meta-analysis of case–control and cohort studies. Nutrition 30(10):1122–1127. https://doi.org/10.1016/j.nut.2014.02.023CrossRefPubMed

29.

Hankin JH, Stram DO, Arakawa K, Park S, Low SH, Lee HP, Yu MC (2001) Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer 39(2):187–195. https://doi.org/10.1207/S15327914nc392_5CrossRefPubMed

30.

Chei CL, Loh JK, Soh A, Yuan JM, Koh WP (2018) Coffee, tea, caffeine, and risk of hypertension: the Singapore Chinese Health Study. Eur J Nutr 57(4):1333–1342. https://doi.org/10.1007/s00394-017-1412-4CrossRefPubMed

31.

Hastie TJ, Tibshirani RJ (1990) Generalized additive models. Chapman and Hall, New York

32.

Wang A, Wang S, Zhu C, Huang H, Wu L, Wan X, Yang X, Zhang H, Miao R, He L, Sang X, Zhao H (2016) Coffee and cancer risk: a meta-analysis of prospective observational studies. Sci Rep 6:33711. https://doi.org/10.1038/srep33711CrossRefPubMedPubMedCentral

33.

Bjorngaard JH, Nordestgaard AT, Taylor AE, Treur JL, Gabrielsen ME, Munafo MR, Nordestgaard BG, Asvold BO, Romundstad P, Davey Smith G (2017) Heavier smoking increases coffee consumption: findings from a Mendelian randomization analysis. Int J Epidemiol 46(6):1958–1967. https://doi.org/10.1093/ije/dyx147CrossRefPubMedPubMedCentral

34.

Fu YY, Takezaki T, Tajima K (1997) Risk factors of lung cancer–follow-up studies in Nagoya Japan. Zhonghua Liu Xing Bing Xue Za Zhi 18(6):328–330PubMed

35.

Spiller MA (1998) The chemical components of coffee. Caffeine. CRC Press, Boca Raton, pp 97–161

36.

Wang G, Bhoopalan V, Wang D, Wang L, Xu X (2015) The effect of caffeine on cisplatin-induced apoptosis of lung cancer cells. Exp Hematol Oncol 4:5. https://doi.org/10.1186/2162-3619-4-5CrossRefPubMedPubMedCentral

37.

Hossain MZ, Gilbert SF, Patel K, Ghosh S, Bhunia AK, Kern SE (2013) Biological clues to potent DNA-damaging activities in food and flavoring. Food Chem Toxicol 55:557–567. https://doi.org/10.1016/j.fct.2013.01.058CrossRefPubMedPubMedCentral

38.

Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9(6):429–439. https://doi.org/10.1038/nrc2641CrossRefPubMedPubMedCentral

39.

Yang CS, Chung JY, Yang GY, Li C, Meng X, Lee MJ (2000) Mechanisms of inhibition of carcinogenesis by tea. BioFactors 13(1–4):73–79CrossRef

40.

Matarrese P, Colasanti T, Ascione B, Margutti P, Franconi F, Alessandri C, Conti F, Riccieri V, Rosano G, Ortona E, Malorni W (2011) Gender disparity in susceptibility to oxidative stress and apoptosis induced by autoantibodies specific to RLIP76 in vascular cells. Antioxid Redox Signal 15(11):2825–2836. https://doi.org/10.1089/ars.2011.3942CrossRefPubMed

41.

Barp J, Araujo AS, Fernandes TR, Rigatto KV, Llesuy S, Bello-Klein A, Singal P (2002) Myocardial antioxidant and oxidative stress changes due to sex hormones. Braz J Med Biol Res 35(9):1075–1081CrossRef

42.

Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M, Tamai H, Takeshita A (2002) Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 22(3):438–442CrossRef

43.

Tang N, Wu Y, Zhou B, Wang B, Yu R (2009) Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer 65(3):274–283. https://doi.org/10.1016/j.lungcan.2008.12.002CrossRefPubMed

44.

Zhong L, Goldberg MS, Gao YT, Hanley JA, Parent ME, Jin F (2001) A population-based case–control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology 12(6):695–700CrossRef

45.

Wang Y, Yu X, Wu Y, Zhang D (2012) Coffee and tea consumption and risk of lung cancer: a dose–response analysis of observational studies. Lung Cancer 78(2):169–170. https://doi.org/10.1016/j.lungcan.2012.08.009CrossRefPubMed

46.

Al-Awaida W, Akash M, Aburubaiha Z, Talib WH, Shehadeh H (2014) Chinese green tea consumption reduces oxidative stress, inflammation and tissues damage in smoke exposed rats. Iran J Basic Med Sci 17(10):740–746PubMedPubMedCentral

47.

Babu PV, Sabitha KE, Shyamaladevi CS (2006) Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats. Chem Biol Interact 162(2):114–120. https://doi.org/10.1016/j.cbi.2006.04.009CrossRefPubMed

48.

Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M (2005) In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7. Med Oncol 22(2):129–138. https://doi.org/10.1385/MO:22:2:129CrossRefPubMed

49.

Crespy V, Williamson G (2004) A review of the health effects of green tea catechins in in vivo animal models. J Nutr 134(12 Suppl):3431S–3440SCrossRef

50.

Wang H, Bian S, Yang CS (2011) Green tea polyphenol EGCG suppresses lung cancer cell growth through upregulating miR-210 expression caused by stabilizing HIF-1alpha. Carcinogenesis 32(12):1881–1889. https://doi.org/10.1093/carcin/bgr218CrossRefPubMedPubMedCentral

51.

Cromie MM, Gao W (2015) Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells. Oxid Med Cell Longev 2015:217304. https://doi.org/10.1155/2015/217304CrossRefPubMedPubMedCentral

52.

Suganuma M, Saha A, Fujiki H (2011) New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102(2):317–323. https://doi.org/10.1111/j.1349-7006.2010.01805.xCrossRefPubMed

Titel: Associations between tea and coffee beverage consumption and the risk of lung cancer in the Singaporean Chinese population
verfasst von: Wei Jie Seow
Woon-Puay Koh
Aizhen Jin
Renwei Wang
Jian-Min Yuan
Publikationsdatum: 10.12.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nutrition / Ausgabe 7/2020
Print ISSN: 1436-6207
Elektronische ISSN: 1436-6215
DOI: https://doi.org/10.1007/s00394-019-02146-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Associations between tea and coffee beverage consumption and the risk of lung cancer in the Singaporean Chinese population

Abstract

Background

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

Skeletal muscle proteome of piglets is affected in a muscle-dependent manner by a limiting total sulfur amino acid supply

Bifidobacteria adolescentis regulated immune responses and gut microbial composition to alleviate DNFB-induced atopic dermatitis in mice

Acute p-synephrine ingestion increases whole-body fat oxidation during 1-h of cycling at Fatmax

Effect of a balanced Korean diet on metabolic risk factors among overweight/obese Korean adults: a randomized controlled trial

Dietary intake of advanced glycation end products (AGEs) and changes in body weight in European adults

Time course of tolerance to adverse effects associated with the ingestion of a moderate dose of caffeine

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin